XML 125 R98.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule II Statement of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Cash Flow Statements, Captions        
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (95,498) $ (29,485) $ 394  
Depreciation and amortization 11,046 11,997 18,482  
Accretion (Amortization) of Discounts and Premiums, Investments 6,422 5,323 5,005  
Unrealized Gain (Loss) on Investments 27,562 (24,761) 9,300  
Net realized gains (losses) (66,691) (1,228) (1,655)  
Increase (Decrease) in Deferred Income Taxes (9,894) (4,280) (2,470)  
Share-based Payment Arrangement, Noncash Expense 1,382 3,007 2,414  
Increase (Decrease) in Accrued Investment Income Receivable 1,221 116 (440)  
Increase (Decrease) in Other Operating Assets (31,917) (6,817) (1,545)  
Accounts payable 12,581 7,544 24,454  
Change in Operating Lease Liability 1,987 324 0  
Increase (Decrease) in Other Operating Liabilities 9,353 15,528 (51,048)  
Net Cash Provided by (Used in) Operating Activities (10,471) 149,015 25,759  
Proceeds from sales and maturities of investments available for sale 695,288 255,197 219,572  
Payments to Acquire Property, Plant, and Equipment (10,848) (21,896) (4,068)  
Net Cash Provided by (Used in) Investing Activities 36,566 (33,979) (125,642)  
Payment, Tax Withholding, Share-based Payment Arrangement (112) (296) (418)  
Repayments of Long-term Debt 1,229 1,523 1,523  
Payments of Debt Issuance Costs 0 0 63  
Payments of Dividends 10,313 10,280 10,268  
Net Cash Provided by (Used in) Financing Activities (11,654) (12,099) 7,728  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 14,441 102,937 (92,155)  
Cash and Cash Equivalents, at Carrying Value 239,420 215,469    
Parent Company        
Condensed Cash Flow Statements, Captions        
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest (95,498) (29,485) 394  
Dividend from Subsidiary 0 (1,764) 51,764  
Depreciation and amortization 2,054 1,131 1,079  
Accretion (Amortization) of Discounts and Premiums, Investments 42 66 (6)  
Unrealized Gain (Loss) on Investments 2,812 (4,036) 1,223  
Net realized gains (losses) (4,971) (63) 160  
Increase (Decrease) in Deferred Income Taxes 644 (511) (570)  
Share-based Payment Arrangement, Noncash Expense 1,382 3,007 2,414  
Increase (Decrease) in Accrued Investment Income Receivable 70 113 (192)  
Increase (Decrease) in Other Operating Assets (3,682) 9,976 (908)  
Accounts payable 931 (22) (524)  
Increase (Decrease) in Notes Payable, Related Parties 6,000 (16,702) 21,975  
Change in Operating Lease Liability (18) 64 0  
Increase (Decrease) in Other Operating Liabilities 966 313 0  
Net Cash Provided by (Used in) Operating Activities (86,505) (37,913) 76,809  
Proceeds from sales and maturities of investments available for sale 32,518 35,036 37,315  
Payments to Acquire Investments (317) (3,567) (72,635)  
Payments to Acquire Interest in Subsidiaries and Affiliates 80,432 20,709 (104,125)  
Payments to Acquire Property, Plant, and Equipment (688) (4,749) (1,032)  
Net Cash Provided by (Used in) Investing Activities 111,945 47,429 (140,477)  
Payment, Tax Withholding, Share-based Payment Arrangement (112) (296) (418)  
Repayments of Long-term Debt (347) (347) (347)  
Payments of Debt Issuance Costs 0 0 (63)  
Proceeds from Issuance of Debt 0 0 0  
Payments of Dividends (10,313) (10,280) (10,268)  
Net Cash Provided by (Used in) Financing Activities (10,772) (10,923) (11,096)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 14,668 (1,407) (74,764)  
Cash and Cash Equivalents, at Carrying Value 17,828 3,160 4,567 $ 79,331
Property, Plant and Equipment, Disposals $ 2,763 $ 0 $ 0